Business Context and Reporting Period
Company: AptarGroup, Inc.
Filing Type: Form 10-K (Annual Report)
Reporting Period: Fiscal year ended December 31, 1997
Business Overview: AptarGroup is a multinational supplier of dispensing packaging systems, including pumps, aerosol valves, and dispensing closures. The company serves the fragrance/cosmetics, personal care, pharmaceutical, household, and food industries. It operates primarily in North America and Europe, with over 1,000 customers and approximately 4,100 employees. The company spun off from Pittway Corporation in 1993.
Key Financial Metrics
Note: Specific consolidated revenue, net income, cash flow, and debt figures are incorporated by reference from the 1997 Annual Report to Stockholders and are not explicitly stated in the provided text.
- Research & Development (R&D): $20.8 million (1997), compared to $20.1 million in 1996 and $17.5 million in 1995.
- Product Mix (Net Sales Contribution):
- Pumps: ~60% (1997), down from 63% (1996) and 65% (1995).
- Dispensing Closures: ~19% (1997), up from 18% (1996) and 16% (1995).
- Aerosol Valves: ~19% (1997), up from 17% (1996) and 18% (1995).
- Geographic Sales: Europe accounted for approximately 55% of net sales in 1997, down from 58% in 1996 and 60% in 1995.
- Market Capitalization: Approximately $915.1 million (based on March 25, 1998 closing price).
- Shares Outstanding: 18,002,860 shares (as of March 25, 1998).
- Allowance for Doubtful Accounts: Ended 1997 at $3.812 million.
Material Changes and Operational Highlights
- International Expansion: The company began production of aerosol valves, pumps, and closures in China in 1997 to enhance its position in Asian markets.
- Product Innovation: Introduced the REPLICA(R) pump for miniature fragrance packages and expanded the use of SimpliSqueeze(R) technology into the non-carbonated beverage market (e.g., sports drinks with Coca-Cola).
- Customer Concentration: No single customer accounted for more than 10% of 1997 net sales, though a consolidation of the customer base is noted as an ongoing trend.
- Legal Proceedings: In Q2 1997, the company received a $7.8 million judgment (plus interest) in a patent infringement lawsuit. This amount is not included in 1997 financial results as the decision was appealed.
Outlook, Risks, and Management Commentary
Outlook and Strategy: Management expects continued growth in pump usage, particularly in cosmetics and pharmaceuticals. The strategy involves geographic expansion, developing innovative products, and converting non-dispensing closures to dispensing closures in various markets.
Risks and Contingencies:
- Foreign Currency: A significant portion of operations is in Europe. A strengthening U.S. dollar would negatively impact financial results, while a weakening dollar has a positive translation effect.
- Regulatory Environment: Government regulations regarding Volatile Organic Compounds (VOCs) and aerosol packaging (e.g., graffiti prevention laws) could restrain demand. Medical cost containment regulations could impact pharmaceutical sales.
- Competition: Markets are highly competitive with price pressure. Competitors range from regional to international entities.
- Supply Chain: The company relies on specific suppliers for unique technical components; delays could impact short-term supply and increase costs.
- Legal: Pending appeals on patent litigation and potential increases in product liability claims due to pharmaceutical applications.
Investor Verification Checklist
- Verify the final outcome and timing of the $7.8 million patent infringement appeal.
- Review the full Consolidated Financial Statements (incorporated by reference) for specific revenue, profit, and debt figures not detailed in this summary.
- Assess the impact of the strengthening/weakening U.S. dollar on future earnings given the 55% European sales exposure.
- Monitor regulatory changes regarding VOCs and aerosol packaging that could affect product demand.
- Confirm the success of the new China manufacturing facility in capturing Asian market share.